| __timestamp | Bristol-Myers Squibb Company | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 85181000 |
| Thursday, January 1, 2015 | 5920000000 | 135253000 |
| Friday, January 1, 2016 | 4940000000 | 162297000 |
| Sunday, January 1, 2017 | 6411000000 | 198442000 |
| Monday, January 1, 2018 | 6345000000 | 226616000 |
| Tuesday, January 1, 2019 | 6148000000 | 299726000 |
| Wednesday, January 1, 2020 | 11143000000 | 335375000 |
| Friday, January 1, 2021 | 10195000000 | 505748000 |
| Saturday, January 1, 2022 | 9509000000 | 590453000 |
| Sunday, January 1, 2023 | 9299000000 | 849658000 |
| Monday, January 1, 2024 | 11159000000 |
Unleashing insights
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc have shown contrasting approaches to R&D investment. From 2014 to 2023, Bristol-Myers Squibb consistently outspent Jazz Pharmaceuticals, with its R&D expenses peaking in 2020 at over 11 billion dollars, a staggering 13 times more than Jazz's highest expenditure in 2023. This significant investment reflects Bristol-Myers Squibb's aggressive strategy to maintain its leadership in the industry. Meanwhile, Jazz Pharmaceuticals has steadily increased its R&D spending, growing by nearly 900% from 2014 to 2023, signaling its ambition to expand its market presence. This showdown highlights the diverse strategies companies employ to drive innovation and secure their future in the ever-evolving pharmaceutical landscape.
Research and Development Investment: Novartis AG vs Jazz Pharmaceuticals plc
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Bristol-Myers Squibb Company vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Bristol-Myers Squibb Company vs Opthea Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Xenon Pharmaceuticals Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.